Your browser doesn't support javascript.
loading
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients.
Schuelke, Matthew R; Bassiri, Hamid; Behrens, Edward M; Canna, Scott; Croy, Colleen; DiNofia, Amanda; Gollomp, Kandace; Grupp, Stephan; Lambert, Michele; Lambrix, Arathi; Maude, Shannon L; Myers, Regina; Newman, Haley; Petrosa, Whitney; Seif, Alix; Sullivan, Kathleen E; Teachey, David T; Diorio, Caroline.
Afiliação
  • Schuelke MR; Pediatrics Residency Program, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Bassiri H; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Behrens EM; Division of Rheumatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Canna S; Division of Rheumatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Croy C; Department of Pharmacy, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • DiNofia A; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Gollomp K; Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Grupp S; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Lambert M; Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Lambrix A; Department of Pharmacy, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Maude SL; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Myers R; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Newman H; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Petrosa W; Immune Dysregulation Program, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Seif A; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Sullivan KE; Division of Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Teachey DT; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Diorio C; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Blood Adv ; 7(18): 5603-5607, 2023 09 26.
Article em En | MEDLINE | ID: mdl-37721859

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Liberação de Citocina / Anticorpos Monoclonais Tipo de estudo: Etiology_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Liberação de Citocina / Anticorpos Monoclonais Tipo de estudo: Etiology_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article